SK bioscience and Sanofi have announced plans for global Phase III studies, which will assess the safety and immunogenicity ...
24/7 Wall St. on MSN8d
Retirees Can Count on Safe Recurring Income From These 6% Dividend StocksHere are three dividend stocks that retirees can buy with confidence as they offer recurring, dependable payouts and a degree ...
24/7 Wall St. on MSN18h
Beware Never-Ending Inflation Baby Boomers: 5 High-Yield Blue Chip Dividend Giants Can HelpQuality, high-yield dividend stocks can deliver dependable passive income to help retirees offset inflation. These five make ...
The company also offers human papillomavirus, valent pneumococcal polysaccharide ... also provides cold chain storage and transportation. It markets its vaccines under the brands Vikant, Gardash, ...
In March 2024, Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union ...
The European Medicines Agency (EMA) has recommended granting marketing authorization for the pneumococcal vaccine Capvaxive (pneumococcal polysaccharide conjugate vaccine [21-valent]) intended to ...
Merck , known as MSD outside of the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the ...
The CDC revised its pneumococcal pneumonia shot recommendation, saying there is a substantial increase in the risk for ...
Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...
Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback